Dixon, Brian E.
Kasting, Monica L.
Wilson, Shannon
Kulkarni, Amit
Zimet, Gregory D.
Downs, Stephen M.
Funding for this research was provided by:
Merck (Regenstrief Project #14)
National Cancer Institute (R25CA117865)
Article History
Received: 21 December 2016
Accepted: 7 August 2017
First Online: 10 August 2017
Ethics approval and consent to participate
: This study received ethics approval from the Institutional Review Board (IRB) at Indiana University (Study No. 1408987170). Respondents were provided a study information sheet and asked verbally to consent to be interviewed. The IRB approved a waiver of written consent because the study presented minimal risk to subjects who were practicing healthcare providers.
: Not applicable.
: The research reported in this article was funded by Merck & Co. through the Merck-Regenstrief Program in Personalized Health Care Research and Innovation, and Gregory Zimet has served as an investigator on research funded by Roche and received travel funds from Merck & Co., Inc. to present research at a scientific conference. Amit Kulkarni is an employee of Merck & Co., Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.